Article

SARS-CoV-2 Omicron BA.2.86: less neutralization evasion compared to XBB sub-variants

2023-09-27

Abstract excerpt

The continual emergence and circulation of new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants have caused a great challenge for the coronavirus disease 2019 (COVID-19) pandemic control. Recently, Omicron BA.2.86 was identified with more than 30 amino acid changes on the spike (S) protein, compared to Omicron BA.2 or XBB.1.5. The immune evasion potential of BA.2.86 is of great concern. In thi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e6bc3445-790d-5d26-a036-3682c0c56ef8
DOI: 10.1101/2023.09.26.559580

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 Omicron BA.2.86: less neutralization evasion compared to XBB sub-variantsDOI 10.1101/2023.09.26.559580Read

Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1Semantic proximity Read

Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariantsSemantic proximity Read

XBB .1.5 neutralizing antibodies upon bivalent COVID ‐19 vaccination are similar to XBB but lower than BQ .1.1Semantic proximity Read

Immune escape of BA.2.86 is comparable to XBB subvariants from the plasma of BA.5- and BA.5-XBB-convalescent subpopulations.Semantic proximity Read

Continued evasion of neutralizing antibody response by Omicron XBB.1.16Semantic proximity Read

Is the BNT162b2 vaccine still effective against the latest variant: XBB.1.5?Semantic proximity Read

Neutralization of SARS-CoV-2 Omicron subvariant BA.2.87.1Semantic proximity Read

An updated atlas of antibody evasion by SARS-CoV-2 Omicron sub-variants including BQ.1.1 and XBBSemantic proximity Read

SARS-CoV-2 Omicron BA.2.12.1, BA.4, and BA.5 subvariants evolved to extend antibody evasionSemantic proximity Read

Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1, and XBB.1 by 4 doses of parental mRNA vaccine or a BA.5-bivalent boosterSemantic proximity Read

Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasionSemantic proximity Read

Potent cross-reactive antibodies following Omicron breakthrough in vaccineesSemantic proximity Read